IL149754A0 - Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same - Google Patents
Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the sameInfo
- Publication number
- IL149754A0 IL149754A0 IL14975400A IL14975400A IL149754A0 IL 149754 A0 IL149754 A0 IL 149754A0 IL 14975400 A IL14975400 A IL 14975400A IL 14975400 A IL14975400 A IL 14975400A IL 149754 A0 IL149754 A0 IL 149754A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- same
- immunogenic portion
- chlamydia antigen
- compositions containing
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45468499A | 1999-12-03 | 1999-12-03 | |
US09/556,877 US6432916B1 (en) | 1998-12-08 | 2000-04-19 | Compounds and methods for treatment and diagnosis of chlamydial infection |
US09/598,419 US6565856B1 (en) | 1998-12-08 | 2000-06-20 | Compounds and methods for treatment and diagnosis of chlamydial infection |
PCT/US2000/032919 WO2001040474A2 (en) | 1999-12-03 | 2000-12-04 | Compounds and methods for treatment and diagnosis of chlamydial infection |
Publications (1)
Publication Number | Publication Date |
---|---|
IL149754A0 true IL149754A0 (en) | 2002-11-10 |
Family
ID=27412613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14975400A IL149754A0 (en) | 1999-12-03 | 2000-12-04 | Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same |
Country Status (16)
Country | Link |
---|---|
US (1) | US6565856B1 (pt) |
EP (1) | EP1238084A2 (pt) |
JP (1) | JP2003515343A (pt) |
KR (1) | KR20020073136A (pt) |
CN (1) | CN1437652A (pt) |
AU (1) | AU1815901A (pt) |
BR (1) | BR0016066A (pt) |
CA (1) | CA2390088A1 (pt) |
CZ (1) | CZ20021897A3 (pt) |
HU (1) | HUP0203705A2 (pt) |
IL (1) | IL149754A0 (pt) |
MX (1) | MXPA02005504A (pt) |
NO (1) | NO20022592L (pt) |
NZ (1) | NZ518917A (pt) |
PL (1) | PL355977A1 (pt) |
WO (1) | WO2001040474A2 (pt) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030219453A1 (en) * | 1998-03-19 | 2003-11-27 | Smithkline Beecham Biologicals, Sa | Vaccines |
US7459524B1 (en) * | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
EP1105489A1 (en) | 1998-08-20 | 2001-06-13 | Aventis Pasteur Limited | Nucleic acid molecules encoding pomp91a protein of chlamydia |
AU5366099A (en) | 1998-08-20 | 2000-03-14 | Connaught Laboratories Limited | Nucleic acid molecules encoding inclusion membrane protein of (chlamydia) |
US6686339B1 (en) | 1998-08-20 | 2004-02-03 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
US6649370B1 (en) | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6607730B1 (en) | 1998-11-02 | 2003-08-19 | Aventis Pasteur Limited/Aventis Pasteur Limitee | Chlamydia antigens and corresponding DNA fragments and uses thereof |
JP2002531093A (ja) | 1998-12-01 | 2002-09-24 | アベンティス、パストゥール、リミテッド | クラミジア抗原および対応するdna断片ならびにその使用 |
US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20080213264A1 (en) * | 1998-12-08 | 2008-09-04 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
CA2354232A1 (en) | 1998-12-08 | 2000-06-15 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US6555115B1 (en) | 1998-12-08 | 2003-04-29 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
US7297341B1 (en) | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
DE69938059T2 (de) | 1998-12-28 | 2009-01-08 | Sanofi Pasteur Ltd., Toronto | Chlamydia antigene, entsprechende dna-fragmente und ihre verwendungen |
GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
CA2365196C (en) | 1999-03-12 | 2011-11-15 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
US20030095973A1 (en) | 1999-05-03 | 2003-05-22 | Murdin Andrew D. | Chlamydia antigens and corresponding DNA fragments and uses thereof |
ATE384793T1 (de) | 1999-09-20 | 2008-02-15 | Aventis Pasteur | Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen |
US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
JP4864264B2 (ja) | 1999-12-22 | 2012-02-01 | サノフィ、パストゥール、リミテッド | クラミジア抗原および対応するdna断片ならびにその使用 |
US6919187B2 (en) * | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
EP2192128A3 (en) * | 2000-04-21 | 2010-09-22 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
CA2408199A1 (en) | 2000-05-08 | 2001-11-15 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
AU2001276619A1 (en) | 2000-07-03 | 2002-01-14 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
US7537772B1 (en) | 2000-10-02 | 2009-05-26 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, gene sequence and the uses thereof |
US7731980B2 (en) * | 2000-10-02 | 2010-06-08 | Emergent Product Development Gaithersburg Inc. | Chlamydia PMP proteins, gene sequences and uses thereof |
GB0103169D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
US6925469B2 (en) * | 2001-03-30 | 2005-08-02 | Intertainer, Inc. | Digital entertainment service platform |
ES2386386T3 (es) | 2001-12-12 | 2012-08-20 | Novartis Vaccines And Diagnostics S.R.L. | Inmunización contra Chlamydia trachomatis |
GB0203403D0 (en) | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
US9132179B2 (en) * | 2003-11-10 | 2015-09-15 | The Uab Research Foundation | Compositions for reducing bacterial carriage and CNS invasion and methods of using same |
EA014527B1 (ru) * | 2005-03-31 | 2010-12-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцины против хламидиоза |
US8541007B2 (en) | 2005-03-31 | 2013-09-24 | Glaxosmithkline Biologicals S.A. | Vaccines against chlamydial infection |
EP1981905B1 (en) * | 2006-01-16 | 2016-08-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Chlamydia vaccine |
WO2008022302A2 (en) * | 2006-08-17 | 2008-02-21 | The Uab Research Foundation | Immunogenic pcpa polypeptides and uses thereof |
NL1033345C1 (nl) * | 2007-02-06 | 2008-08-07 | Vereniging Voor Christelijk Ho | Werkwijze voor het detecteren van Chlamydia trachomatis en een kit daarvoor. |
US8440208B2 (en) * | 2007-05-01 | 2013-05-14 | Board Of Regents, The University Of Texas System | Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease |
EP2185577A4 (en) * | 2007-08-03 | 2010-09-22 | Harvard College | CHLAMYDIA ANTIGENS |
US7892567B2 (en) * | 2007-10-01 | 2011-02-22 | Board Of Regents, The University Of Texas System | Methods and compositions for immunization against chlamydial infection and disease |
US8637053B2 (en) * | 2007-12-03 | 2014-01-28 | President And Fellows Of Harvard College | Chlamydia antigens |
JP4798125B2 (ja) * | 2007-12-13 | 2011-10-19 | 株式会社デンソー | 照度センサ |
JP2012505212A (ja) | 2008-10-09 | 2012-03-01 | ボード・オヴ・リージェンツ,ユニヴァーシティ・オヴ・テキサス・システム | クラミジア感染および疾患の診断および治療のためのクラミジア抗原に関する方法および組成物 |
US8204859B2 (en) * | 2008-12-10 | 2012-06-19 | Commvault Systems, Inc. | Systems and methods for managing replicated database data |
EP2403526B1 (en) | 2009-03-06 | 2019-05-15 | GlaxoSmithKline Biologicals SA | Chlamydia antigens |
JP5811086B2 (ja) | 2010-03-23 | 2015-11-11 | 和光純薬工業株式会社 | クラミジア・トラコマティス検出用プライマー及びプローブ、並びにこれを用いたクラミジア・トラコマティスの検出方法 |
KR20210076881A (ko) | 2018-03-08 | 2021-06-24 | 어플라이드 몰레큘라 트랜스포트 인크. | 경구 전달용 독소-유래 전달 구조체 |
EP3826682A4 (en) | 2018-11-07 | 2021-11-17 | Applied Molecular Transport Inc. | CARRIERS MADE FROM CHOLIX FOR ORAL ADMINISTRATION OF A HETEROLOGICAL PAYLOAD |
TW202120521A (zh) | 2019-08-16 | 2021-06-01 | 美商應用分子運輸公司 | 組合物、配方及介白素生產及純化 |
CN112779248B (zh) * | 2021-02-04 | 2022-12-02 | 杭州遂曾生物技术有限公司 | 一种沙眼衣原体一体化核酸检测卡盒 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4118469A (en) | 1976-04-27 | 1978-10-03 | Research Corporation | Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU) |
US4497863A (en) | 1984-03-07 | 1985-02-05 | Milliken Research Corporation | Laminated weft insertion fabric |
US5166053A (en) | 1990-02-23 | 1992-11-24 | Miles Inc. | Specimen adequacy control for chlamydia assays |
JP3018553B2 (ja) | 1990-05-08 | 2000-03-13 | 日立化成工業株式会社 | クラミジア・トラコマティス抗体測定方法及びクラミジア・トラコマティス感染症診断用製剤 |
US5549978A (en) | 1992-10-30 | 1996-08-27 | Kabushiki Kaisha Toshiba | Magnetoresistance effect element |
CN100365017C (zh) | 1994-09-20 | 2008-01-30 | 日立化成工业株式会社 | 肺炎衣原体抗原多肽 |
GB9516293D0 (en) | 1995-08-09 | 1995-10-11 | Immunova Ltee | Novel peptides and their use as vaccines |
EP0915978B1 (en) | 1996-07-12 | 2005-12-14 | University of Manitoba | Dna immunization against chlamydia infection |
US6464979B1 (en) | 1996-09-12 | 2002-10-15 | Aventis Pasteur Limited | Chlamydial vaccines and methods of preparation thereof |
EP1854885B9 (en) | 1997-11-21 | 2011-03-16 | Merck Serono Biodevelopment | Chlamydia pneumoniae outer membrane polypeptide, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
KR100760221B1 (ko) | 1997-11-28 | 2007-10-30 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
AU753995B2 (en) | 1998-04-07 | 2002-10-31 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
CA2354232A1 (en) | 1998-12-08 | 2000-06-15 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
-
2000
- 2000-06-20 US US09/598,419 patent/US6565856B1/en not_active Expired - Fee Related
- 2000-12-04 PL PL00355977A patent/PL355977A1/xx unknown
- 2000-12-04 MX MXPA02005504A patent/MXPA02005504A/es unknown
- 2000-12-04 AU AU18159/01A patent/AU1815901A/en not_active Abandoned
- 2000-12-04 CN CN00818118A patent/CN1437652A/zh active Pending
- 2000-12-04 CZ CZ20021897A patent/CZ20021897A3/cs unknown
- 2000-12-04 JP JP2001542539A patent/JP2003515343A/ja not_active Withdrawn
- 2000-12-04 NZ NZ518917A patent/NZ518917A/xx unknown
- 2000-12-04 BR BR0016066-0A patent/BR0016066A/pt not_active IP Right Cessation
- 2000-12-04 IL IL14975400A patent/IL149754A0/xx unknown
- 2000-12-04 CA CA002390088A patent/CA2390088A1/en not_active Abandoned
- 2000-12-04 WO PCT/US2000/032919 patent/WO2001040474A2/en not_active Application Discontinuation
- 2000-12-04 KR KR1020027007135A patent/KR20020073136A/ko not_active Application Discontinuation
- 2000-12-04 EP EP00980969A patent/EP1238084A2/en not_active Withdrawn
- 2000-12-04 HU HU0203705A patent/HUP0203705A2/hu unknown
-
2002
- 2002-05-31 NO NO20022592A patent/NO20022592L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1437652A (zh) | 2003-08-20 |
CZ20021897A3 (cs) | 2003-02-12 |
EP1238084A2 (en) | 2002-09-11 |
PL355977A1 (en) | 2004-05-31 |
WO2001040474A3 (en) | 2002-03-07 |
AU1815901A (en) | 2001-06-12 |
WO2001040474A2 (en) | 2001-06-07 |
KR20020073136A (ko) | 2002-09-19 |
BR0016066A (pt) | 2003-06-10 |
JP2003515343A (ja) | 2003-05-07 |
CA2390088A1 (en) | 2001-06-07 |
NZ518917A (en) | 2004-06-25 |
MXPA02005504A (es) | 2002-10-31 |
NO20022592L (no) | 2002-07-19 |
NO20022592D0 (no) | 2002-05-31 |
HUP0203705A2 (hu) | 2003-03-28 |
US6565856B1 (en) | 2003-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL149754A0 (en) | Polypeptides containing an immunogenic portion of a chlamydia antigen and pharmaceutical compositions containing the same | |
IL142216A0 (en) | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same | |
IL150224A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
EG24044A (en) | pharmaceutical formulation of omeprazole | |
IL150223A0 (en) | Lipopeptides and pharmaceutical compositions containing the same | |
AU7912100A (en) | Pharmaceutical composition comprising an antigen | |
EP1254666A4 (en) | STABLE ANTIBODY COMPOSITIONS AND INJECTION FORMULATIONS | |
PL343491A1 (en) | Pharmaceutical aerosol formulation | |
PL331531A1 (en) | Pharmaceutical aerosol compositions | |
IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
HUP0100149A3 (en) | Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
IL146230A0 (en) | 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
LT99141A (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide | |
IL145733A0 (en) | A polpyeptide containing an immunogenic portion of a breast protein and pharmaceutical compositions containing the same | |
HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
AP2001002371A0 (en) | Streptogramin derivatives preparation and compositions containing them | |
CZ2000522A3 (cs) | Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití | |
IL125908A (en) | Peptides and pharmaceutical compositions comprising same | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
HUP0003330A3 (en) | Pharmaceutical compositions containing tizoxanide and nitazoxanide | |
ZA9811470B (en) | Pharmaceutical compositions based on dalfopristine and on quinupristine and their preparation | |
HK1046925A1 (zh) | Mage-a12抗原肽及其用途 | |
IL131266A0 (en) | Peptides and pharmaceutical compositions comprising same | |
HRP970615B1 (en) | Stabilized pharmaceutical compositions with quinupristine and dalfopristine base and their preparation |